MCVAX | VMVIX | MCVAX / VMVIX | |
Total Expense Ratio | 1.19 | 0.19 | 626% |
Annual Report Gross Expense Ratio | 1.19 | 0.19 | 626% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 8.333 | 6.685 | 125% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 979M | 32B | 3% |
Annual Yield % from dividends | 1.01 | 2.04 | 50% |
Returns for 1 year | -1.05 | 4.45 | -24% |
Returns for 3 years | 5.66 | 30.16 | 19% |
Returns for 5 years | 14.55 | 66.63 | 22% |
Returns for 10 years | 9.00 | 102.78 | 9% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GK | 26.21 | 0.07 | +0.28% |
AdvisorShares Gerber Kawasaki ETF | |||
FIAX | 18.17 | 0.02 | +0.14% |
Nicholas Fixed Income Alternative ETF | |||
VUSE | 66.60 | 0.01 | +0.02% |
Vident U.S. Equity Strategy ETF | |||
CPSL | 26.78 | -0.06 | -0.22% |
Calamos Laddered S&P 500 Str Alt Prt ETF | |||
SDY | 139.38 | -0.40 | -0.29% |
SPDR® S&P Dividend ETF |